Ledger.Open graph →
SEC Form D · filed September 1, 2016

Tilos Therapeutics, Inc

Offering
$1.5M
Sold
$750K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Martin Heidecker · Medford, MADirectorJulius Knowles · Waltham, MADirectorRoger Kitterman · Arlington, MADirectorBarbara Fox · Waltham, MAExec · DirectorMartin Heidecker · Santa Monica, CADirectorRoger Kitterman · Waltham, MADirectorBarbara Fox · Waltham, MAExec · DirectorJulius Knowles · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗